Map Details - Hypertension and RASA Nonadherence in Arkansas
Impact Statement
This map describes the geographic disparity of hypertension and nonadherence to antihypertensive medication among the Medicare population.
Findings
The striking patterns of high prevalence for both in the southern and eastern portions of the state support a need for strong interventions among this population. Findings have been shared with programs working on hypertension initiatives in the health department and will be shared with partners to initiate and sustain activities in this area.
Software Used
ArcGIS 10.4 ESRI
Data Used
Medicare fee-for-service claims data for 2015, Chronic Condition Warehouse, Centers for Medicare & Medicaid Services; Medicare Part D claims data for 2014, Centers for Medicare & Medicaid Services obtained through the Interactive Atlas of Heart Disease and Stroke, Centers for Disease Control and Prevention.
Methods Used
County-level hypertension prevalence among Medicare fee-for-service beneficiaries was obtained from the Chronic Condition Warehouse. County-level Renin-Angiotensin System Antagonist (RASA) nonadherence prevalence among Medicare Part D beneficiaries was obtained from the CDC Interactive Atlas of Heart Disease and Stroke. Arkansas hypertension and RASA nonadherence prevalence were mapped using the quantile classification method in ArcGIS 10.4.
Contact the Submitter of this Map
Lucy Im, Epidemiologist, Arkansas Department of Health
501-280-4365
lucy.im@arkansas.gov
How to Cite this Map
Im, L. “Hypertension and RASA Nonadherence in Arkansas” [map]. July, 2017. Arkansas Department of Health. Accessed from the Centers for Disease Control and Prevention’s Chronic Disease GIS Exchange http://www.cdc.gov/dhdsp/maps/gisx/mapgallery/
- Page last reviewed: August 30, 2017
- Page last updated: August 30, 2017
- Content source: